Crohn's disease is a chronic inflammatory bowel disease increasingly diagnosed in children and adolescents worldwide. Nutriti- -onal status, growth, pubertal development and quality of life in pediatric Crohn's disease gets impacted. Nutritional therapy has become an important part of disease management due to the adverse effects of long-term corticosteroid and immunosupp- -ressive therapy. The Crohn’s Disease Exclusion Diet (CDED), usually in combination with Partial Enteral Nutrition (PEN), has emerged as a promising dietary therapy for induction and maintenance of remission in pediatric Crohn’s disease. The present literature review is an evaluation of the impact of CDED on pediatric Crohn’s disease using data from published clinical trials, observational studies, review articles, and case series from 2014 to 2024. Several studies have shown that CDED with PEN results in clinical remission, reduction of inflammatory markers such as C-reactive protein (CRP) and fecal calprotectin, improvement of serum albumin levels and nutritional status . CDED was better tolerated than exclusive enteral nutrition (EEN) and showed better adherence, better weight gain and better quality of life due to the presence of selected whole foods. Several studies also showed favorable results in patients who had received biologic therapy or failed biologics. The review also emphasizes CDED’s role in modulating gut microbiota,improvingintestinal permeability, and reducing intestinal inflammation by eliminating processed foods and saturated fats that are associated with dysbiosis. International evidence overwhelmingly supports the use of CDED in pediatric Crohn’s disease; however, Indian literature on CDED is extremely sparse and a solitary research study. An Indian study focused on Exclusive Enteral Nutrition and not on exclusion diets. Hence, there is a need for large Indian studies to validate efficacy, biochemical outcomes, adherence and sustainability among Indian pediatric population.